SLE‐associated myelitis successfully treated by rituximab

Systemic lupus erythematosus (SLE) is an autoimmune disease. Transverse myelitis (TM) is one of the rare neurological manifestations of SLE. Here, we present a case of SLE in which TM precede other symptoms and successfully treated by Rituximab.

Detalles Bibliográficos
Autores principales: Khabbazi, Alireza, Ghadakchi, Leyla, Yazdani, Yalda, Habibzade, Elham, Mehrtabar, Saba, Khalaji, Amirreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676124/
https://www.ncbi.nlm.nih.gov/pubmed/36419577
http://dx.doi.org/10.1002/ccr3.6622
_version_ 1784833518674640896
author Khabbazi, Alireza
Ghadakchi, Leyla
Yazdani, Yalda
Habibzade, Elham
Mehrtabar, Saba
Khalaji, Amirreza
author_facet Khabbazi, Alireza
Ghadakchi, Leyla
Yazdani, Yalda
Habibzade, Elham
Mehrtabar, Saba
Khalaji, Amirreza
author_sort Khabbazi, Alireza
collection PubMed
description Systemic lupus erythematosus (SLE) is an autoimmune disease. Transverse myelitis (TM) is one of the rare neurological manifestations of SLE. Here, we present a case of SLE in which TM precede other symptoms and successfully treated by Rituximab.
format Online
Article
Text
id pubmed-9676124
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96761242022-11-22 SLE‐associated myelitis successfully treated by rituximab Khabbazi, Alireza Ghadakchi, Leyla Yazdani, Yalda Habibzade, Elham Mehrtabar, Saba Khalaji, Amirreza Clin Case Rep Case Report Systemic lupus erythematosus (SLE) is an autoimmune disease. Transverse myelitis (TM) is one of the rare neurological manifestations of SLE. Here, we present a case of SLE in which TM precede other symptoms and successfully treated by Rituximab. John Wiley and Sons Inc. 2022-11-20 /pmc/articles/PMC9676124/ /pubmed/36419577 http://dx.doi.org/10.1002/ccr3.6622 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Report
Khabbazi, Alireza
Ghadakchi, Leyla
Yazdani, Yalda
Habibzade, Elham
Mehrtabar, Saba
Khalaji, Amirreza
SLE‐associated myelitis successfully treated by rituximab
title SLE‐associated myelitis successfully treated by rituximab
title_full SLE‐associated myelitis successfully treated by rituximab
title_fullStr SLE‐associated myelitis successfully treated by rituximab
title_full_unstemmed SLE‐associated myelitis successfully treated by rituximab
title_short SLE‐associated myelitis successfully treated by rituximab
title_sort sle‐associated myelitis successfully treated by rituximab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676124/
https://www.ncbi.nlm.nih.gov/pubmed/36419577
http://dx.doi.org/10.1002/ccr3.6622
work_keys_str_mv AT khabbazialireza sleassociatedmyelitissuccessfullytreatedbyrituximab
AT ghadakchileyla sleassociatedmyelitissuccessfullytreatedbyrituximab
AT yazdaniyalda sleassociatedmyelitissuccessfullytreatedbyrituximab
AT habibzadeelham sleassociatedmyelitissuccessfullytreatedbyrituximab
AT mehrtabarsaba sleassociatedmyelitissuccessfullytreatedbyrituximab
AT khalajiamirreza sleassociatedmyelitissuccessfullytreatedbyrituximab

Ejemplares similares